ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer.
Pestalozzi
B C
BC
Div. of Oncology, Universitätspital, CH-8091 Zürich, Switzerland.
Luporsi-Gely
E
E
Jost
L M
LM
Bergh
J
J
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D015994:Incidence; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment
D018931:Antineoplastic Agents, Hormonal